MedPath

MEZERA

MEZERA

Approved
DIN Number

02474026

Drug Class

Human

Market Date

Jul 13, 2018

Company
HC

avir pharma inc.

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02474026
AIG Number0116808012
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
A07EC02 MESALAZINE
Product Specifications
Dosage FormFoam
Route of AdministrationRectal
AHFS Classification56:36.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

MESALAZINEActive
Strength: 1 G / ACT
Monograph: MESALAZINE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.